41st week of 2013 patent applcation highlights part 43 |
Patent application number | Title | Published |
20130267556 | AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS - Azaindoles having inhibitory activity on RSV replication and having the formula I | 2013-10-10 |
20130267557 | Combined Use of an Alpha-Adrenergic Receptor Antagonist and an Anti-Muscarinic Agent - The combined use of (R)-5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzene-1-sulfonamide (tamsulosin), or its pharmaceutically acceptable salt, and (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid (3R)-quinuclidin-3-yl ester (solifenacin), or its pharmaceutically acceptable salt, for the preparation of a medicament for the improvement of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) with a substantial storage component is provided. | 2013-10-10 |
20130267558 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ALCOHOLIC LIVER DISEASES, CONTAINING CILOSTAZOL AS ACTIVE INGREDIENT - Provided is a pharmaceutical composition for the treatment and prevention of alcoholic liver diseases, including cilostazol as an active ingredient. Cilostazol inhibits expression levels of TNF-α and FAS (fatty acid synthase) gene in a concentration-dependent manner, and also significantly inhibits the activity of caspase-3. Accordingly, cilostazol shows superior effects for the treatment or prevention of alcoholic liver diseases, in particular, alcoholic hepatitis compared to pentoxifylline which is conventionally used as a therapeutic agent for the treatment for alcoholic hepatitis. Thus, cilostazol is suitable for use as a drug for the treatment or prevention of alcoholic hepatitis. | 2013-10-10 |
20130267559 | Quinolinone Derivatives - The present invention relates to compounds which are quinolinone derivatives of general formula (I) capable of modulating the activity, in particular of inducing the differentiation, of stem and progenitor cells; these compounds are of use in the treatment of disorders related to a stem differentiation defect; the invention also relates to novel compounds among these quinolinone derivatives and to pharmaceutical compositions containing the same. | 2013-10-10 |
20130267560 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS OF DONEPEZIL - The present invention relates to sustained release pharmaceutical compositions of donepezil or pharmaceutically acceptable salts thereof. The compositions of the invention are stable and provide sustained therapeutically effective plasma levels over a twenty four hour period with reduced incidences of cholinergic side effects. The invention also relates to process of making such compositions. | 2013-10-10 |
20130267561 | Substituted 1,3-Dioxanes Useful as PPAR Modulators - Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases. | 2013-10-10 |
20130267562 | ACTIVE ENANTIOMER OF DODECYL 2-(N,N-DIMETHYLAMINO)-PROPIONATE - 2R-dodecyl 2-(N,N dimethylamino)-propionate (R-DDAIP) provides an unexpectedly improved activity in facilitating transport of a pharmaceutically active compound across biological membranes and tissues, compared to S-DDAIP of the same enantiomeric purity, or racemic DDAIP. Purified S-DDAIP is also provided. | 2013-10-10 |
20130267563 | HETEROARYLS AND USES THEREOF - This invention provides compounds of formula IA or IB: wherein HY, R | 2013-10-10 |
20130267564 | BENZYLOXYPYRIMIDINE DERIVATIVE, AGRICULTURAL/ HORTICULTURAL INSECTICIDE COMPRISING DERIVATIVE AND METHOD FOR USING SAME - A benzyloxypyrimidine derivative represented by the formula (I) | 2013-10-10 |
20130267565 | 4- (METHYLAMINOPHENOXY) PYRDIN -3- YL - BENZAMIDE DERIVATIVES FOR TREATING CANCER - The present invention provides a novel compound having an excellent antitumor effect, stability and metabolic stability. The compound of the present invention is represented by the following general formula (1) wherein R | 2013-10-10 |
20130267566 | DURABLE TREATMENT WITH 4-AMINOPYRIDINE IN PATIENTS WITH DEMYELINATION - Disclosed herein are methods and compositions related to the durable use of aminopyridines, such as 4-aminopyridine, to improve impairments of patients with a demyelinating condition, such as MS. | 2013-10-10 |
20130267567 | Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid - The invention relates to novel multicomponent crystals, to the production thereof, and to the use thereof for treating pain conditions, in particular of unclear genesis, by means of a simultaneous effect on pains which are caused by muscle tension or degenerative joint diseases as well as on pains that are caused by inflammatory processes. The multicomponent crystals according to the invention contain ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester (flupirtine) and an arylpropionic acid as the sole active ingredient combination and can be produced by dissolving flupirtine and the arylpropionic acid in an inert organic solvent and subsequently crystallizing the multicomponent crystal. | 2013-10-10 |
20130267568 | (1,2,3-Triazolyl)sulfonyl Derivatives - The invention relates to a compound of the formula | 2013-10-10 |
20130267569 | Hydroxylated Aminotriazole Derivatives as ALX Receptor Agonists - The invention relates to hydroxylated aminotriazole derivatives of formula (I), | 2013-10-10 |
20130267570 | STABLE AND AQUEOUS CONCENTRATED PRESERVATIVE COMPOSITION OF DEHYDROACETIC ACID (DHA) AND METHYLISOTHIAZOLINONE (MIT) - An aqueous, stable, highly-concentrated preservative composition comprising (i) about 5 to 50 wt % of a dehydroacetic acid (DHA) or a salt thereof; (ii) about 1 to 20 wt % of a 2-methyl-4-isothiazolin-3-one (MIT); (iii) about 0.1 to 10 wt % of at least one block copolymer; (iv) optionally, about 0.01 to 5.0 wt % of at least one sulfosuccinate surfactant; (v) optionally, about 0.01 to 5.0 wt % of at least one sequestering agent; and (vi) optionally, about 0.01 to 5.0 wt % of one or more additives. Also disclosed is a process for preparing said preservative composition. | 2013-10-10 |
20130267571 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS - The present application provides a terpene analogue of Formula (I) or a pharmaceutically acceptable isomer, salt or ester thereof, and methods and uses thereof for treating neurological conditions such as pain in general and neuropathic pain. These terpene analogues can also be used to treat other electrical disorders in the central and peripheral nervous system. Also provided are methods of synthesizing the terpene analogues of Formula I. | 2013-10-10 |
20130267572 | Plymorphic Forms of Deferasirox (ICL670A) - The invention relates to crystalline forms of 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and to its amorphous form, to processes for the preparation thereof, to compositions containing the same and their uses for the manufacture of a medicament for the treatment of the human body. | 2013-10-10 |
20130267573 | CRYSTALLINE FORMS OF AN ALKOXYIMIDAZOL-1-YLMETHYL BIPHENYL CARBOXYLIC ACID - The invention provides crystalline salt forms of 4′-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]-imidazol-1-ylmethyl}-3′-fluorobiphenyl-2-carboxylic acid. This invention also provides pharmaceutical compositions comprising the crystalline compounds, processes and intermediates for preparing the crystalline compounds, and methods of using the crystalline compounds to treat diseases such as hypertension. | 2013-10-10 |
20130267574 | Polymorphic Forms of Asenapine Maleate and Processes for their Preparation - Are disclosed new crystalline forms of asenapine maleate, useful in the production of pharmaceutical formulations for the treatment of diseases of the central nervous system, in particular schizophrenia; processes for the production of these new crystalline forms are also disclosed. | 2013-10-10 |
20130267575 | CANCER TREATMENT TARGETING NON-CODING RNA OVEREXPRESSION - Provided herein are methods directed to modulating the pro-oncogenic effects of noncoding RNAs (ncRNAs) through their interactions with specificity protein transcription factors (SpTFs). In one aspect, the disclosure provides a method of inhibiting growth of a cell, such as a transformed or cancer cell, characterized by overexpression of at least one specificity protein (Sp)-regulated ncRNA and expression of at least one Sp transcription factor (SpTF), the method comprising contacting the cell with an effective amount of an SpTF agent. In some embodiments, the ncRNA is a long noncoding RNA (lncRNA). In some embodiments, the ncRNA is a microRNA (miR). Also provided are methods of treating a cell proliferative disease, predicting the response of a subject to SpTF agent-based treatment, and monitoring the efficacy of a SpTF agent-based treatment in a subject. | 2013-10-10 |
20130267576 | (NUCLEIC ACID)-POLYSACCHARIDE COMPLEX - The present invention provides a nucleic acid-polysaccharide complex that is highly stable and has reduced cytotoxicity in a high yield. That is, the present invention provides a nucleic acid-polysaccharide complex of an antisense DNA having polydeoxyadenine (dA) as a polysaccharide binding site and a polysaccharide having a β-1,3-glucan skeleton wherein at least part of phosphodiester links of the polydeoxyadenine is phosphorothioated (provided that the phosphodiester links of the antisense DNA and the polydeoxyadenine are not entirely phosphorothioated). | 2013-10-10 |
20130267577 | Gene Silencing by Single-Stranded Polynucleotides - The present invention relates to compositions and methods for concurrently activating antisense and double-stranded RNase (dsRNase) mechanisms for inhibiting expression of a targeted gene, by delivering a single stranded bifunctional chimeric DNA/RNA oligonucleotide optimized for siRNA activity as well as antisense activity, into the nucleus of a target cell. | 2013-10-10 |
20130267578 | COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION - The invention relates to one or more inhibitors, in particular siRNAs, which down-regulate the expression of a NOX gene selected from the group consisting of NOX4, NOX1, NOX2 (gp91phox, CYBB), NOX5, DUOX2, NOXO1, NOXA1 and NOXA2 (p67phox). The invention also relates to a pharmaceutical composition comprising the compound, or a vector capable of expressing the compound, and a pharmaceutically acceptable carrier. The present invention also contemplates a method of treating or preventing the incidence or severity of various diseases or conditions associated with NOX gene comprising administering to the patient the pharmaceutical composition in a therapeutically effective dose so as to thereby treat the patient. | 2013-10-10 |
20130267579 | Methods and Compositions for Inducing Deregulation of EPHA7 and ERK Phosphorylation in Human Acute Leukemias - Methods for assessing a pathological condition in a subject include measuring one or more markers where a difference is indicative of acute lymphoblastic leukemia (ALL) or a predisposition to ALL, uses and compositions are disclosed. | 2013-10-10 |
20130267580 | Compositions and Methods for the Diagnosis and Therapy of BCL2-Associated Cancers - Provided are methods and compositions for the treatment of cancers associated with overexpression of a BCL2 gene and/or gene product in a subject, and methods and compositions for the improvement of anti-cancer therapy, such as chemotherapy and radiation therapy. Also provided are methods for determining the efficacy of a cancer therapy in a subject, methods for diagnosing cancer, methods for assessing patient prognosis, and methods for inducing apoptosis of a cell. | 2013-10-10 |
20130267581 | AGENT FOR TREATING MYELOFIBROSIS - Disclosed is a substance delivery carrier for an extracellular-matrix-producing cell in the bone marrow, which comprises a retinoid. Also disclosed in an agent for treating myelofibrosis by utilizing a substance capable of regulating the activity or proliferation of an extracellular-matrix-producing cell in the bone marrow. | 2013-10-10 |
20130267582 | ADENO-ASSOCIATED VIRUS 2/8 - MICRO RNA-101 THERAPY FOR LIVER CANCER - Adeno-associated virus 2/8-microRNA-101(AAV2/8-miR-101) therapy for liver cancer is provided. In particular, the invention provides a recombinant AAV 2/8 vector, comprising mutated capsid, for the enforced expression of pre-miR-101 and for the treatment of liver cancer. | 2013-10-10 |
20130267583 | IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE - The invention provides novel immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit or suppress TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen. | 2013-10-10 |
20130267584 | APTAMERS TO TISSUE FACTOR PATHWAY INHIBITOR AND THEIR USE AS BLEEDING DISORDER THERAPEUTICS - The present invention provides compositions and methods for modulating TFPI protein plasma concentration and TFPI protein function. Such modulation can be used to treat blood disorders such as bleeding disorders and clotting disorders. | 2013-10-10 |
20130267585 | PHARMACEUTICAL COMPOSITION HAVING A CATIONIC EXCIPIENT - A pharmaceutical composition comprising a pharmaceutically effective amount of a pharmaceutically active substance and a pharmaceutically acceptable carrier including a cationic excipient, wherein said cationic excipient is a labile ester of betaine and a lipophilic alcohol having at least one primary hydroxyl group. Also, the use of a labile ester of betaine and a lipophilic alcohol having at least a primary hydroxyl group as a cationic excipient in a carrier for a pharmaceutical composition comprising a pharmaceutically active substance. | 2013-10-10 |
20130267586 | Compound - The present invention provides compounds of the formula Formula I or a salt thereof: and the uses of such compounds for the treatment of a disease or disorder involving oxidative damage, for preventing UV damage to the skin of a mammal and for preventing or reversing the effects of ageing, or for treating or preventing dry skin. | 2013-10-10 |
20130267587 | PHARMACEUTICAL TOPICAL COMPOSITION OF MUPIROCIN - Anhydrous topical gel composition of mupirocin or its salts comprising: a) a lipophilic base selected from the group consisting of petrolatum, medium-chain triglycerides, isopropyl myristate and mixtures thereof; b) a bioadhesive selected from the group comprising polyvinylpyrrolidone and polymethacrylates; and c) a solvent selected from the group comprising ethanol, propanol, and isopropanol; which is stable and shows an increased residence time of the active ingredient in the skin, resulting in an improved clinical effect in the treatment of bacterial skin infections while maintaining the safety profile of the commercial pharmaceutical product. | 2013-10-10 |
20130267588 | HYDROXYTYROSOL ETHERS - The invention relates to hydroxytyrosol ethers derived from fatty alcohols and phenolic compounds of olive oil and the salts, solvates and hydrates thereof, which have an affinity for type 1 cannabinoid receptors (CB1) and which can: prevent the oxidation of low-density lipoprotein (LDL); and modulate the actions regulated by said receptor, such as inducing satiety, controlling intake and reducing body fat. | 2013-10-10 |
20130267589 | FUSED CYCLIC COMPOUNDS - The present invention provides a compound represented by the formula (I): | 2013-10-10 |
20130267590 | RETIGABINE COMPOSITIONS - Stable premixes comprising retigabine, or pharmaceutically acceptable salts thereof, and at least one pharmaceutically acceptable carrier, and process for preparing the same are disclosed. Stable premixes comprising retigabine, or pharmaceutically acceptable salts thereof, and at least one pharmaceutically acceptable inorganic carrier, and processes for preparing the same and incorporating them in compositions that are employed for therapeutic uses and methods of treatment. | 2013-10-10 |
20130267591 | NOVEL OPHTHALMIC COMPOSITIONS - An ophthalmic solution comprising therapeutically effective amount of a prostaglandin or its analog and water soluble excipient(s) dissolved in a pharmaceutically acceptable vehicle, wherein the solution is free of a surfactant. | 2013-10-10 |
20130267592 | DERIVATIVES OF 1-(2-HALO-BIPHENYL-4-YL)-ALKANECARBOXYLIC ACIDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - Pro-drugs of 1-(2-halo-biphenyl-4-yl)alkanecarboxylic acids are useful for preventing and/or treating neurodegenerative diseases, improving cognitive function and treating cognitive impairment. | 2013-10-10 |
20130267593 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN - Administration of Oxybutynin directly to a patient's lungs for treating urinary incontinence, respiratory disease or IBD. | 2013-10-10 |
20130267594 | PROLYL HYDROXYLASE INHIBITORS AS RADIATION MITIGATORS AND RADIATION PROTECTORS - A method to inhibit tissue injury in a subject resulting from exposure to radiation is provided. The method involves administering to the subject a prolyl hydroxylase (PH) inhibitor in an amount effective to inhibit tissue injury caused by radiation exposure of the subject. The invention also involves a screen for PH inhibitors that inhibit tissue damage resulting from exposure to radiation. Compounds that inhibit the enzymatic activity of PHs are tested for their ability to protect against radiation damage. | 2013-10-10 |
20130267595 | MICROBIOLOGICALLY SOUND AND STABLE SOLUTIONS OF GAMMA-HYDROXYBUTYRATE SALT FOR THE TREATMENT OF NARCOLEPSY - Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient. | 2013-10-10 |
20130267596 | Methods of Reducing Hair Loss and/or Facilitating Hair Growth and/or Regrowth - The present disclosure relates to methods of retarding hair loss or facilitating hair growth and/or regrowth. More specifically, the present disclosure relates to methods of using the disclosed compositions to increase the rate of terminal hair growth and/or regrowth in a mammal. | 2013-10-10 |
20130267597 | POLYUNSATURATED FATTY ACID-CONTAINING SOLID FAT COMPOSITIONS AND USES AND PRODUCTION THEREOF - The present invention provides a solid fat composition that includes an oil having saturated fat and an oil having at least one long chain polyunsaturated fatty acid. In particular, the solid fat composition can have high levels of long chain polyunsaturated fatty acid and low to no presence of emulsifiers. In preferred embodiments, the polyunsaturated oil is an unwinterized microbial oil. The invention also relates to methods for making such compositions and food, nutritional, and pharmaceutical products comprising said compositions. | 2013-10-10 |
20130267598 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the inhibition of sebum production. | 2013-10-10 |
20130267599 | USE OF TRANS-PALMITOLEATE IN IDENTIFYING AND TREATING METABOLIC DISEASE - The present invention provides for a novel lipokine, trans-C16:1n7-palmitoleate, which also serves as a biomarker for metabolic status. More specifically, low concentrations of trans-C16:1n7-palmitoleate the serum indicates a risk of metabolic disease. Additionally, administering trans C16:1n7-palmitoleate to a subject (via pharmaceutical, nutraceutical, or other means), positively impacts glucose metabolism. | 2013-10-10 |
20130267600 | Concentrate of Omega 3 - An efficient and simple process to obtain a concentrate that includes over 80% in weight of ethyl esters of ω-3 fatty acids based on a composition of matter that contains esters of ω-3 fatty acids or free ω-3 fatty acids that comprises the stages of:
| 2013-10-10 |
20130267601 | Method for prevention of alzheimer's disease - A method for prevention of Alzheimer's Disease (AD) is presented. The principal cause of AD is a deficiency at the cellular level of the human brain, of the effects of the active form of thyroid hormone, tri-iodothyronine (T3). Lifelong T3 replacement, beginning in early to mid life and, in some cases later, overcomes these blocks to T3 production and actions and prevents AD in a majority of the sub-types of AD. | 2013-10-10 |
20130267602 | MOISTURE RESISTANT CONTAINER SYSTEMS FOR RAPIDLY BIOAVAILABLE DOSAGE FORMS - Provided are rapidly bioavailable solid oral dosage forms of acute pain medications, and moisture resistant packaging that enables the formulation of such rapidly bioavailable dosage forms. | 2013-10-10 |
20130267603 | COMPOSITIONS AND METHODS FOR LOWERING COUNTS OF PATHOGENIC MICROORGANISMS IN FOOD PRODUCTS - Compositions and methods for lowering counts of pathogenic microorganisms in food products such as ready to eat meat and poultry products are disclosed. In various embodiments, the compositions and methods comprise antimicrobial compositions with one or more essential oils added. | 2013-10-10 |
20130267604 | PROTECTED ANTIMICROBIAL COMPOUNDS FOR HIGH TEMPERATURE APPLICATIONS - Provided are protected antimicrobial compounds which are useful for controlling microorganisms in aqueous or water-containing systems, such as oil or gas field fluids, at elevated temperature. The antimicrobial compounds are of the formula I: | 2013-10-10 |
20130267605 | AQUEOUS COMPOSITION COMPRISING BROMHEXINE - The present invention relates to aqueous compositions containing bromhexine, the composition comprising an amount of sugar alcohols of less than 10 g based on 100 ml of the composition, and the use thereof for secretolytic therapy in acute and chronic bronchopulmonary disorders. | 2013-10-10 |
20130267606 | USE OF VITAMIN K FOR WEIGHT MAINTENANCE AND WEIGHT CONTROL - Vitamin K is effective in counteracting (1) increase of body weight and body mass index (BMI), (2) accumulation of body fat mass and (3) accelerates weight loss during calory restriction or other life style interventions aiming weight reduction. A pharmaceutical composition or nutritional formulation comprising vitamin K is provided which can be used to combat overweight or obesity, either as a single, dedicated product or in combination with other slimming products or life style change | 2013-10-10 |
20130267607 | LAXATIVE GEL COMPOSITION - An edible, gel composition of a PEG and a gel forming agent wherein the composition is prepared by mixing together the PEG with gel forming agent to form the edible gel composition, and the edible gel composition has laxative properties. | 2013-10-10 |
20130267608 | SOLID, EDIBLE, CHEWABLE LAXATIVE COMPOSITION - An edible, solid composition comprising a laxative and one or more bulking agents in aqueous media wherein the laxative is polyethylene glycol and the composition is prepared by dissolving the polyethylene glycol in aqueous media together with one or more bulking agents and subjecting the mixture to heat up to at least about 100° C. | 2013-10-10 |
20130267609 | NOVEL LIPID DIPEPTIDE AND GEL - There is provided a gelator that is capable of forming a gel by an extremely small amount of addition in a wide pH range from acidic to alkaline regions, and a gel having high environmental compatibility, biocompatibility, and biodegradability. A gelator comprising: a lipid peptide of Formula (1) wherein R | 2013-10-10 |
20130267610 | NOVEL LIPID DIPEPTIDE AND GEL - There is provided a gelator that is capable of forming a gel by an extremely small amount of addition in a wide pH range from acidic to alkaline regions, and a gel having high environmental compatibility, biocompatibility, and biodegradability. A gelator comprising: a lipid peptide of Formula (1) wherein R | 2013-10-10 |
20130267611 | COSMETIC COMPOSITION COMPRISING A SUPRAMOLECULAR COMPOUND CAPABLE OF ESTABLISHING HYDROGEN BONDS, A SILICONE OIL AND A WAX - The present invention relates to a solid cosmetic composition comprising, in a cosmetically acceptable medium, (i) a supramolecular compound that may be obtained by reaction between:—at least one oil bearing at least one nucleophilic reactive function chosen from OH and NH | 2013-10-10 |
20130267612 | INSTANT POWDERS FOR AQUEOUS COSMETIC APPLICATIONS - A personal care composition includes a blend of a cold water soluble starch, a naturally derived polymeric thickener and a cosmetically or pharmaceutically acceptable active, where the composition is in the form of a solid. | 2013-10-10 |
20130267613 | MOLECULAR-DETERMINANT BASED TYPING OF KIR ALLELES AND KIR-LIGANDS - The present invention relates to an assay to perform a molecular determinant-based functional killer immunoglobulin-like receptors (KIR) allele typing and ligand typing. In particular the present invention provides methods, compositions, and kits for a single nucleotide polymorphism (SNP) assay to type various allele groups of KIR2DL1 and KIR ligand with distinct functional properties based on polymorphism at position 245 in KIR2DL1, position 77 in HLA-C, and position 83 in HLA-B and HLA-A. The assays are suitable for use in predicting NK cell activity in health, disease, and transplantation. | 2013-10-10 |
20130267614 | BIOGAS TO LIQUID FUEL CONVERTER - There is disclosed a biogas to liquid fuel converter. In an embodiment, the biogas to liquid fuel converter includes a gas cleaning system, a cargo container including a syngas production system and a methanol synthesis system to produce methanol. In another embodiment, a method of making a liquid fuel includes converting a landfill gas or a sewage digester gas using a biogas to liquid fuel converter. | 2013-10-10 |
20130267615 | PROCESS FOR PRODUCTION OF DIMETHYL ETHER AT A DME-FPSO SYSTEM FOR CONVERSION OF ASSOCIATED GAS IN OIL FIELDS AND STRANDED GAS IN STRANDED GAS FIELDS - Disclosed are methods for producing dimethyl ether using a dimethyl ether (DME)-floating, production, storage and offloading (FPSO) system that can be used in offshore oil fields or stranded gas fields. More particularly, the disclosure relates to producing dimethyl ether from gas extracted from stranded gas fields or from associated gas extracted from oil fields at an FMSO facility, which includes a reforming reactor and a dimethyl ether reactor equipped offshore. | 2013-10-10 |
20130267616 | Polymerisation Method - A method of forming a polymer is provided, the method comprising: Providing a first monomer comprising one or more aromatic moieties, the first monomer comprising at least two amino groups, each of the amino groups being attached to an aromatic moiety; and contacting said first monomer with formaldehyde or a source of methylene. Polymers made by such a method and uses of such polymers are also described. | 2013-10-10 |
20130267617 | PROCESS OF FABRICATING A CAST FOAM PRODUCT, A CAST FOAM PRODUCT AND AN INTERMEDIATE FOAM PRODUCT - Disclosed is a process of fabricating a cast foam product, an intermediate foam product, and a cast foam product. The process includes positioning an expandable component and alloying particles within a die and injecting steam into the die and expanding the expandable component to form an expanded component. The expandable component includes one or more of polystyrene and polymethylmethacrylate. The intermediate foam product includes the alloying particles, the expandable component, and the steam. The cast foam product includes a distribution of the alloying particles and the expanded component, with the alloying particles being physically bound by the expanded component. | 2013-10-10 |
20130267618 | Foamable fluoropolymer compositions - The invention pertains to foamable thermoplastic fluoropolymer composition comprising:
| 2013-10-10 |
20130267619 | EPDM FOAM, PRODUCING METHOD THEREOF, AND SEALING MATERIAL - An EPDM foam is obtained by foaming a foam composition containing, based on 100 parts by weight of an ethylenepropylenediene rubber, 0.1 to 5 parts by weight of a vulcanizer, 0.1 to 10 parts by weight of a vulcanization accelerator, 1 to 30 parts by weight of a foaming agent, and a foaming auxiliary agent. The vulcanization accelerator contains a thiourea vulcanization accelerator, a thiazole vulcanization accelerator, a dithiocarbamate vulcanization accelerator, and a thiuram vulcanization accelerator such that a thiourea vulcanization accelerator/thiazole vulcanization accelerator/dithiocarbamate vulcanization accelerator/thiuram vulcanization accelerator weight ratio is in a range of 1 to 20/1 to 20/1 to 20/1 to 30. | 2013-10-10 |
20130267620 | Process for the production of expanded plastic materials, in particular PVC-based polymeric foams and a formulation of a polymeric blend for effecting said process - A perfected process for the production of expanded plastic materials, comprising a hot moulding phase of a starting polymeric blend inside a mould, wherein the heating of said blend is effected by making the same a heat source, by triggering an exothermic reaction in its interior. With respect to the known art in the field, the process of the invention allows an improvement in the heating of the polymeric mass inside the mould, reducing the times necessary for effecting it and homogenizing the thermal values inside this mass. | 2013-10-10 |
20130267621 | POLYTETRAFLUOROETHYLENE MIXTURE - Provided is a material that can be easily biaxially oriented, homogeneously stretched even with a high draw ratio, and formed into a PTFE porous membrane with low pressure loss. The present invention relates to a polytetrafluoroethylene mixture comprising: a fibrillable modified polytetrafluoroethylene; and a fibrillable polytetrafluoroethylene homopolymer, the polytetrafluoroethylene homopolymer having strength at break of 25 N or higher. | 2013-10-10 |
20130267622 | Hydrophilic vinylidene fluoride polymers - The present invention pertains to a process for the manufacture of a grafted fluorinated polymer comprising at least one grafted side chain comprising one or more glycosidic recurring units [polymer (F)], said process comprising polymerizing:
| 2013-10-10 |
20130267623 | THERMOPLASTIC RESIN FOAM AND PROCESS FOR PRODUCING THE SAME - Disclosed is a thermoplastic resin foam which is obtained by subjecting a thermoplastic resin composition containing a thermoplastic elastomer and an active-energy-ray-curable resin to foam molding to give a foamed structure, and irradiating the foamed structure with an active energy ray to allow the active-energy-ray-curable resin to form a cross-linked structure in the foamed structure. Also disclosed is a thermoplastic resin foam which is obtained by subjecting a thermoplastic resin composition containing a thermoplastic elastomer, an active-energy-ray-curable resin, and a thermal cross-linking agent to foam molding to give a foamed structure, irradiating the foamed structure with an active energy ray to allow the active-energy-ray-curable resin to form a cross-linked structure in the foamed structure, and heating the resulting foamed structure bearing the cross-linked structure to thereby allow the thermal cross-linking agent to form another cross-linked structure in the foamed structure. | 2013-10-10 |
20130267624 | NOVEL INK COMPOSITIONS CONTAINING ISOSORBIDE-CAPPED AMIDE GELLANT - Disclosed herein are ester-terminated polyimide gellant compounds end-caped with isosorbide and UV curable ink compositions containing them. | 2013-10-10 |
20130267625 | ACTIVE RAY CURABLE COMPOSITION, ACTIVE RAY CURABLE INK COMPOSITION FOR INKJET PRINTING, ACTIVE RAY CURABLE ADHESIVE COMPOSITION, AND METHOD FOR STABILIZING ACTIVE RAY CURABLE COMPOSITION - An active ray curable composition, including: a photobase generator; a polymerizable compound; and an acid, wherein the photobase generator is a salt of a carboxylic acid and a basic compound, wherein a ratio by mole of a carboxyl group of the carboxylic acid:a basic functional group of the basic compound is 1:1, and wherein the acid is an acid that loses a function thereof as acid by light or heat. | 2013-10-10 |
20130267626 | PHOTOCURABLE COMPOSITION - The present invention allows for a photocurable composition which exhibits stable physical characteristics in a heat resistance test and an oil resistance test, and exhibits good debubbling properties and excellent workability. A photocurable composition including components (A) to (C).
| 2013-10-10 |
20130267627 | PRIMER FOR INK-JET RECORDING - The present invention relates to a primer ink comprising a polymerizable compound and a polymerization initiator, wherein the polymerizable compound comprises a monofunctional monomer having an aromatic hydrocarbon-based ring structure in a molecule and an aliphatic hydrocarbon-based monofunctional monomer, wherein a total mass of the monofunctional monomer having an aromatic hydrocarbon-based ring structure in a molecule and an aliphatic hydrocarbon-based monofunctional monomer is 80% by mass or more based on the total mass of all polymerizable compounds which the primer ink comprises, and wherein a surface tension of is 25 mN/m to 31 mN/m and a viscosity is 50 mPa·s or less. | 2013-10-10 |
20130267628 | SILICONE ELASTOMER MATERIAL SUITABLE FOR USE IN PARTICULAR FOR MAKING DENTAL IMPRESSIONS - Described are organopolysiloxane compositions that are capable of cross-linking and/or of hardening by polyaddition reactions so as to produce elastomers or materials made of silicone. Further described, is how the composition is useful for making a dental impression in the context of preparing prostheses. | 2013-10-10 |
20130267629 | MESOPOROUS SILICA PARTICLES, METHOD FOR PRODUCING MESOPOROUS SILICA PARTICLES, AND MESOPOROUS SILICA PARTICLE-CONTAINING MOLDED ARTICLE - The mesoporous silica particles each comprise a core particle comprising first mesopores, wherein a periphery of the core particle is covered with silica. Preferably, second mesopores, smaller than the first mesopores, are provided in the silica-covered part formed by the silica covering. The mesoporous silica particles are produced by: a surfactant complex silica particle preparation step of mixing a surfactant, water, an alkali, a hydrophobic part-containing additive and a silica source to thereby prepare surfactant complex silica particles, said hydrophobic part-containing additive including a hydrophobic part for increasing a volume of micelles to be formed by the surfactant; and a silica covering step of adding the silica source to the surfactant complex silica particles to thereby cover a periphery of each core particle with silica. | 2013-10-10 |
20130267630 | GLASS BUBBLE, MASTER BATCH INCLUDING THE SAME, AND RESIN PARTICLE WITH METAL FILM FORMED ON SURFACE THEREOF - Disclosed herein are glass bubbles that are surface treated to obtain a metallic texture, and have a similar specific gravity to that of plastic. Thus, there is a low possibility of occurrence of appearance defects even when a material obtained by compounding the glass bubbles and the plastic is injection molded and a master batch including the glass bubbles and plastic to improve a miscibility of the glass bubbles and the plastic. The glass bubbles each include a spherical shell and a surface treatment layer formed on a surface of the shell, the spherical shell having a hollow hole so as to decrease a specific gravity of the glass bubbles and the surface treatment layer being formed by surface treatment to obtain a metallic texture. | 2013-10-10 |
20130267631 | MULTIFUNCTIONAL BIOCOMPOSITE ADDITIVE COMPOSITIONS AND METHODS - Biocomposite compositions and compositions, which include dried distillers solubles, and which can be used in making biocomposite compositions are described. Methods for preparing the compositions are also described. | 2013-10-10 |
20130267632 | Aqueous starch containing polymer dispersion for paper applications - The invention concerns an aqueous starch-containing polymer dispersion obtainable by co-polymerisation of ethylenically unsaturated monomers comprising: (a) from 20 to 50 wt % of at least one of styrene or substituted styrene; (b) from 20 to 60 wt % t-butyl (meth)acrylate; and, (c) from 0 to 20 wt % of at least one ethylenically unsaturated co-polymerisable monomer being different from (a) and (b), in the presence of (d) from 10 to 50 wt % cationic starch, wherein the sum of (a)+(b)+(c)+(d) is 100%. The invention further concerns preparation and use thereof. | 2013-10-10 |
20130267633 | Stabilized Polyolefins Having Increased Agrochemical and UV Resistance and Methods of Use - Polyolefin thin films having a stabilizing amount of a stabilizer composition including:
| 2013-10-10 |
20130267634 | FLAME RETARDANT POLYCARBONATE RESIN COMPOSITION, FLAME RETARDANT FOR POLYCARBONATE RESIN, AND METHOD FOR PRODUCING SAME - The present invention discloses a polycarbonate resin composition and molded article thereof with excellent flame resistance, no problem with clouding, and excellent haze properties and color tone values. The flame retardant polycarbonate resin composition wherein (B) a metal salt of an organic sulfonic acid and (C) a compound with inclusion capability are contained in (A) a polycarbonate resin, and a flame retardant for a polycarbonate resin comprising an inclusion compound in which (B) a metal salt of an organic sulfonic acid is enclosed by (C) a compound with inclusion capability. | 2013-10-10 |
20130267635 | IMPACT-MODIFIED POLYCARBONATE COMPOSITIONS FOR SIMPLIFIED PRODUCTION OF COMPONENTS OF LOW TEMPERATURE TOUGHNESS HAVING HIGH GLOSS AND MATT COMPONENT SECTIONS - The present invention relates to impact-modified polycarbonate moulding compositions, the use thereof for producing shaped bodies and mouldings, as well as shaped bodies and moulding produced therefrom themselves. Compositions of the present invention comprise mixtures of graft polymers prepared in the emulsion polymerization process and in the bulk, solution and/or suspension polymerization process having a defined grafted particle size distribution. Compositions of the present invention, on the one hand are suitable for producing, over a wide processing window, (i.e. also at high processing temperatures), non-lacquered components having a high gloss surface, and on the other hand, are also capable of precise imaging of fine-grained or surface-etched mould surfaces. A result of this point is that components of the present invention are capable of having both high gloss and deep matte component sections that can be realized in a mould having different surface textures in a single injection moulding step without further after-treatment of the surface. The moulding compositions have a high heat distortion temperature and ductility at low temperatures and an excellent resistance to stress cracking under the influence of media—which is particularly important with respect to non-lacquered components. | 2013-10-10 |
20130267636 | PROCESS FOR PREPARING HIGH MELT STRENGTH PROPYLENE POLYMERS - A process for preparing high melt strength propylene polymers is provided. The process comprises: blending base propylene polymers with 0.1 to 1% w/w of polyfunctional acrylate monomer, in the presence of 10 to 50 ppm organic peroxide and 0.2 to 20% w/w of an additive such as stabilizer, acid neutralizer, antioxidants or lubricants. The high strength modified propylene polymers obtained have 30 to 60% of increased melt strength than that of the base propylene polymers. | 2013-10-10 |
20130267637 | Reduction In Modulus of Polyurethane Sealants and Adhesives - Low modulus, polyurethane sealant or adhesive compositions and a method of reducing the modulus of a polyurethane sealant or adhesive composition, including adding a modulus reducing additive of at least one of rosin esters, hydrogenated rosin esters, or mixtures thereof, to a sealant or adhesive composition including a polyurethane prepolymer, optionally having a bio-based content of from about 15% to about 75% by weight. | 2013-10-10 |
20130267638 | METHOD FOR MANUFACTURING RUBBER COMPOSITION - The present invention relates to a method for producing a rubber composition containing a rubber component (A) of at least one selected from natural rubbers and synthetic dienic rubbers, a filler containing an inorganic filler (B), a silane coupling agent (C) and a vulcanization promoter (D), wherein the rubber composition is kneaded in multiple stages, and in the first stage of kneading, the rubber component (A), all or a part of the inorganic filler (B), and all or a part of the silane coupling agent (C) are kneaded, and then on the way of the first stage, the vulcanization promoter (D) is added and further kneaded. The production method enables production of a rubber composition having a low-heat-generation property while successfully preventing the coupling function activity of the silane coupling agent from lowering. | 2013-10-10 |
20130267639 | THERMOPLASTIC POLYURETHANES COMPOSITION AND PREPARATION PROCESSES THEREOF - This invention is directed to a thermoplastic polyurethanes composition comprising polyether-based thermoplastic polyurethane and 1,2-cyclohexane dicarboxylic acid ester and preparation processes thereof. The thermoplastic polyurethane composition has a good mold release behavior in injection molding without undesirably significant shrinkage and surface blooming of final product. | 2013-10-10 |
20130267640 | SNOW TYRE TREAD - A snow tyre with an improved grip on wet ground includes a tread formed of a rubber composition. The rubber composition includes: 20 to 100 phr of a first diene elastomer bearing at least one SiOR function, with R being hydrogen or a hydrocarbon radical, and with phr referring to parts by weight per hunder parts of elastomer; 100 to 160 phr of a reinforcing inorganic filler; and a plasticizing system. The plasticizing system includes: a content A of between 10 and 60 phr of a hydrocarbon resin having a Tg above 20° C.; and a content B of between 10 and 60 phr of a liquid plasticizing agent. A total content A+B is greater than 50 phr. Optionally, the rubber composition also includes 0 to 80 phr of a second diene elastomer. | 2013-10-10 |
20130267641 | AUTOMOTIVE LAMP EXTENSION MOLDING - [Problem to be Solved] The present invention has an object to provide an automotive lamp extension molding comprising a resin composition having a low specific gravity, being excellent in the balance of heat resistance and fluidity, and being excellent in gloss and brightness feeling of the surface of the molded article. | 2013-10-10 |
20130267642 | HIGH DAMPING RUBBER PREPARATION RAW MATERIAL FOR CAR VIBRATION REDUCTION PRODUCT - The present invention makes public a type of car vibration damping products using high damping rubber compound materials, involving the rubber technical field, whose features are the following ones: chloride butyl, 100; carbon black N220, 10-40; carbon black N330, 20-50; naphthenic oil H-3107, 20-40; age resister RD, 1-3; age resister 4010NA, 1-3; homogenizing agent 40MSF, 3-6; indirect zinc oxide, 5-10; magnesium oxide, 0.1-0.5; accelerating agent BZ, 1-5. | 2013-10-10 |
20130267643 | Binder Composition - An aqueous binder composition for a paint comprising an oligomeric or polymeric substance formed from at least one monomer of the general formula I: | 2013-10-10 |
20130267644 | ACRYLATE RUBBER RAW MATERIAL COMPOSITION FOR CRANKCASE VENTILATION HOSE - The present invention makes public a type of acrylate rubber materials used in crankcase ventilation pipes, which belongs to the technological field of rubber and has the following characteristic qualities: acrylate rubber PA 402L, 40-70; acrylate rubber PA 402H, 30-60; stearic acid, 1-2; age resister Dusantox 86, 2-3; processing agent Vanfre VAM, 1-2; carbon black N330, 25-45; carbon black N550, 10-30; potassium stearate, 0.2-0.5; sodium stearate, 1-4; brimstone, 0.1-0.3. The oil resistance of this acrylate rubber made by the above mentioned materials is superior than the now commonly used acrylate rubber's, its heat resistance corresponds to ethylene acrylate rubber's and its cost is cheaper. | 2013-10-10 |
20130267645 | WEATHER-RESISTANT CROSSLINKED POLYOLEFIN COMPOSITION, POLYOLEFIN SHEET MADE FROM THE SAME AND METHOD FOR MAKING THE SHEET - A weather-resistant crosslinked polyolefin composition is a novel formula containing a comprehensive mixture constituted by crosslinking agent, antistatic agent, TiO | 2013-10-10 |
20130267646 | RUBBER COMPOSITION FOR TIRE TREAD AND PNEUMATIC TIRE USING THE SAME - A rubber composition for tire tread contains a diene-based rubber including 30 wt % or more of a terminal modifying group-containing conjugated diene-based copolymer, silica, carbon black, and at least one of silane coupling agents represented by specified formulae. The total amount of silica and carbon black in the composition is 35 to 140 parts by weight relative to 100 parts by weight of the diene-based rubber, while the silane coupling agent content is 4 to 18 wt % on the silica content. The copolymer is produced by a specified method such that the aromatic vinyl monomer content in the copolymer is 38 to 48 wt %, the vinyl unit content in all the conjugated diene-based monomers is 20 to 35 mol %, the weight average molecular weight of the copolymer is 600,000 to 1,000,000, and the terminal modifying group in the copolymer contains a functional group which interacts with the silica. | 2013-10-10 |
20130267647 | POLYVINYL ACETAL RESIN FOR THERMOFORMING - An object of the invention is to provide a polyvinyl acetal resin for thermoforming that allows providing a molded product that is excellent in thermal stability, and excellent in the heat resistance without harming the properties of the polyvinyl acetal resin, and the invention relates to a polyvinyl acetal resin for thermoforming, which is obtained by acetalization of a polyvinyl alcohol resin having a viscosity average polymerization degree of 500 to 2000 and a saponification degree of 99.5 mol % or more with aldehyde, wherein the sum of vinyl alcohol units acetalized with the aldehyde is 65 to 88 mol % with respect to the total repeating units, and the content of alkali metal or alkali earth metal is 0.1 to 50 ppm. The molar ratio of a vinyl alcohol unit acetalized with an aldehyde having four or more carbon atoms/a vinyl alcohol unit acetalized with an aldehyde having three or less carbon atoms is preferably 90/10 to 0/100. | 2013-10-10 |
20130267648 | Process for Preparing a Particulate Solid, a Particulate Solid and a Dispersion - According to a first aspect of the present invention there is provided a process for preparing a particulate solid comprising the steps i) to iv): i) providing a dispersion of polymer particles in a liquid medium, said polymer being obtained or obtainable by the copolymerisation of at least the monomers in components a) to d): a) 45 to 90 parts of one of more hydrocarbyl (meth) acrylates each having a homopolymer Tg of from 90 to 130° C. and having no hydrophilic groups; b) 10 to 55 parts of one or more ethylenically unsaturated monomers each having homopolymer Tg of below 90° C. and having no hydrophilic groups; c) 0 to 40 parts of one or more styrenic monomers having a homopolymer Tg of at least 90° C. and having no hydrophilic groups; d) 0 to 10 parts of one or more ethylenically unsaturated monomers each having at least one hydrophilic group; wherein all the parts are by weight; ii) associating the particles to form clusters of particles; iii) optionally stabilising the clusters; iv) heating the clusters above the glass transition of the polymer. | 2013-10-10 |
20130267649 | CONJUGATED DIENE RUBBER, RUBBER COMPOSITION, CROSS-LINKED RUBBER, AND TIRE - A conjugated diene rubber of the present invention is prepared from conjugated diene polymer chains, wherein the conjugated diene polymer chains each has an active end at one end and an isoprene block at least at the other end, the isoprene block contains 70 wt % or more isoprene monomer units, and the active ends of at least part of the conjugated diene polymer chains are modified with a compound having a >C═O group as a functional group. This provides (i) a tire that has an excellent strength, excellent low-heat buildup property, and excellent wet grip property and (ii) a rubber composition and a conjugated diene rubber that are suitably used to produce the tire. | 2013-10-10 |
20130267650 | Colored High Strength Polyethylene Fiber and Preparation Method Thereof - A colored high strength polyethylene fiber, preparation method and use thereof are provided, which are in the high molecular material field. The surface of said high strength polyethylene fiber is chromatic, grey or black. The strength of said high strength polyethylene fiber is 15-50 g/d, its modulus is 400-2000 g/d. The product of the present invention is colored, so it can be well applied to civil and military field. The preparation method of present invention has some advantages that technological process is simple, production efficiency is high, cost of production is low, performance of made fiber is excellent, and use-cost is reduced, compared with the prior art. | 2013-10-10 |
20130267651 | POLYSILOXANE-GRAFTED POLYIMIDE RESIN COMPOSITION AND FLEXIBLE SUBSTRATE MADE THEFEFROM - A polysiloxane-grafted polyimide resin composition includes a polysiloxane-grafted polyimide resin, and a solvent. The polysiloxane-grafted polyimide resin is represented by Formula (I): | 2013-10-10 |
20130267652 | METHODS OF HYDROPHOBIZING MATERIALS WITH SILOXANES CONTAINING HYDROCARBYLIMINOALKYL OR QUATERNARY AMMONIUM SALTS - A method of coating a surface of a base material, includes:
| 2013-10-10 |
20130267653 | ADDITION-CURABLE METALLOSILOXANE COMPOUND - Provided is a metallosiloxane compound (A) prepared by reacting a bifunctional silane compound (S1), a monofunctional silane compound (S2), a boron compound (M), and optionally H | 2013-10-10 |
20130267654 | SILICONE ASPARTATE COPOLYMERS - Aspartate-containing silicone copolymers are prepared in high yield and with low reaction time by preparing a monoester of hydroxyl functional polyether by reaction of the latter with maleic anhydride, and then reacting with a silicone containing at least one primary or secondary amino group. | 2013-10-10 |
20130267655 | MOLDED POLYURETHANE ELASTOMER PARTS MADE OF DIPHENYLMETHANE DIISOCYANATE-BASED NCO PREPOLYMERS AND METAL SALT COMPLEXES, AND A METHOD FOR PRODUCING SAME - The invention relates to novel molded polyurethane elastomer parts made of diphenylmethane diisocyanate-based NCO-functional prepolymers and diphenylmethandiamine blocked with metal salts and to a method for producing same. | 2013-10-10 |